Kyntra Bio (KYNB) Work In Process (2018 - 2024)

Kyntra Bio has disclosed Work In Process across 7 years of filings, most recently posting $3.2 million for Q4 2024.

• In Q4 2024, Work In Process fell 80.75% year-over-year to $3.2 million; the TTM figure through Dec 2024 stood at $3.2 million (down 80.75% YoY), while the FY2024 annual figure was $3.2 million, down 80.75% from the prior year.
• Work In Process came in at $3.2 million for Q4 2024 at Kyntra Bio, down from $17.8 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $37.3 million in Q1 2023 to a low of $2.9 million in Q1 2020.
• Average Work In Process over 5 years is $20.6 million, with a median of $20.0 million recorded in 2024.
• Year-over-year, Work In Process jumped 307.37% in 2021 and slumped 80.75% in 2024.
• Over 5 years, Work In Process stood at $8.1 million in 2020, then jumped by 164.96% to $21.5 million in 2021, then surged by 67.46% to $36.0 million in 2022, then plunged by 54.49% to $16.4 million in 2023, then tumbled by 80.75% to $3.2 million in 2024.
• Per Business Quant data, the three most recent Work In Process figures were $3.2 million in Q4 2024, $17.8 million in Q3 2024, and $19.5 million in Q2 2024.